Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR4784 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SARS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIMM10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ECHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FIBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF34 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R14B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADAMTS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DBI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKHD1-EIF4EBP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRDX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMZ2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM126A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on